Fig. 3
From: The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
A Comparisons between PD and non-PD in the change levels of NO after administration of lenvatinib. B Comparisons between PD and non-PD in the change rate of NO after administration of lenvatinib. C Comparisons between the absence and presence of SAE in the change levels of NO after administration of lenvatinib. D Comparisons between the absence and presence of SAE in the change rate of NO after administration of lenvatinib